Literature DB >> 10379628

Cyanamide reduces brain catalase and ethanol-induced locomotor activity: is there a functional link?

C Sanchis-Segura1, M Miquel, M Correa, C M Aragon.   

Abstract

The present study was designed in an attempt to assess a previously suggested role of brain catalase activity in ethanol-induced behaviour by examining ethanol-induced locomotor activity in cyanamide-treated mice. Mice were pretreated with IP injections of the catalase inhibitor cyanamide (3.75, 7.5, 15, 30 or 45 mg/kg) or saline. Following this treatment, animals in each group received IP injections of ethanol (0.0, 1.6, 2.4 or 3.2 g/kg) and locomotion was recorded. Several time intervals (0, 5, 10, 15, 20 or 25 h) between the two treatments were also evaluated. Results indicated that cyanamide administration produced a dose-dependent decrease in ethanol-induced locomotor activity that depends on the time between treatments. However, cyanamide did not change spontaneous or d-amphetamine-induced locomotor activity. Moreover, an additive effect of cyanamide and another brain catalase inhibitor, 3-amino-1,2,4-triazole (AT), on the reduction of ethanol-induced locomotor activity was observed. Perfused brain homogenates of mice treated with cyanamide, AT or cyanamide+AT showed a significant reduction of brain catalase activity. The dose and time patterns of both effects were closely related and a significant correlation between them was obtained. These results suggest that cyanamide could reduce locomotor activity through its inhibition of brain catalase, giving further support to the notion that brain catalase may be an important regulator of some ethanol-induced behavioural effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10379628     DOI: 10.1007/s002130050980

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  8 in total

1.  Ethanol-induced conditioned place preference, but not aversion, is blocked by treatment with D -penicillamine, an inactivation agent for acetaldehyde.

Authors:  Laura Font; Carlos M G Aragon; Marta Miquel
Journal:  Psychopharmacology (Berl)       Date:  2005-12-13       Impact factor: 4.530

2.  α-Lipoic acid, a scavenging agent for H₂O₂, reduces ethanol-stimulated locomotion in mice.

Authors:  Juan Carlos Ledesma; Carlos M G Aragon
Journal:  Psychopharmacology (Berl)       Date:  2011-07-19       Impact factor: 4.530

3.  Reduction in the anxiolytic effects of ethanol by centrally formed acetaldehyde: the role of catalase inhibitors and acetaldehyde-sequestering agents.

Authors:  M Correa; H M Manrique; L Font; M A Escrig; C M G Aragon
Journal:  Psychopharmacology (Berl)       Date:  2008-06-30       Impact factor: 4.530

4.  Acquisition and reconditioning of ethanol-induced conditioned place preference in mice is blocked by the H₂O₂ scavenger alpha lipoic acid.

Authors:  Juan Carlos Ledesma; Carlos M G Aragon
Journal:  Psychopharmacology (Berl)       Date:  2012-08-11       Impact factor: 4.530

5.  Role of acetaldehyde in ethanol-induced conditioned taste aversion in rats.

Authors:  M Dolores Escarabajal; Philippe De Witte; Etienne Quertemont
Journal:  Psychopharmacology (Berl)       Date:  2003-03-25       Impact factor: 4.530

Review 6.  Pre-Clinical Studies with D-Penicillamine as a Novel Pharmacological Strategy to Treat Alcoholism: Updated Evidences.

Authors:  Alejandro Orrico; Lucía Martí-Prats; María J Cano-Cebrián; Luis Granero; Ana Polache; Teodoro Zornoza
Journal:  Front Behav Neurosci       Date:  2017-03-07       Impact factor: 3.558

7.  Brain Levels of Catalase Remain Constant through Strain, Developmental, and Chronic Alcohol Challenges.

Authors:  Dennis E Rhoads; Cherly Contreras; Salma Fathalla
Journal:  Enzyme Res       Date:  2012-08-05

8.  Involvement of the endogenous opioid system in the psychopharmacological actions of ethanol: the role of acetaldehyde.

Authors:  Laura Font; Miguel Á Luján; Raúl Pastor
Journal:  Front Behav Neurosci       Date:  2013-07-31       Impact factor: 3.558

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.